If you've been watching the stock market or health news, you might have noticed Hims & Hers stock making big moves. This surge isn't just about telehealth; it's deeply connected to a surprising new frontier in weight loss and anti-aging treatments.
Hims & Hers stock (HIMS) recently jumped over 30% in a single day, continuing a strong upward trend.
This significant increase on May 6th, 2024, followed their Q1 earnings report and an announcement about expanding into weight loss treatments, specifically mentioning GLP-1s and a new peptide-based offering.